Aptar PharmaProduct InfoAptar Pharma Launches First Metal-Free Highly Recyclable Nasal Spray PumpAptar Pharma announces the launch of APF Futurity, its first metal-free, multidose nasal spray pump ...
Aptar PharmaCompany NewsAptar Pharma Announces Collaboration with TFF PharmaceuticalsAptar Pharma announces collaboration with TFF Pharmaceuticals to develop intranasal delivery of dry ...
Aptar PharmaProduct InfoFirst Nasally-Administered Pharmaceutical Treatment for Dry Eye Disease Approved by US FDA with Aptar’s Nasal Pump SystemAptar Pharma’s patented Cartridge Pump System (CPS), was recently reviewed by the U.S. FDA as the dr...
Aptar PharmaProduct InfoAptar Pharma's nasal unidose device approved for Tosymra sumatriptan sprayAptar Pharma, a leading provider of drug delivery devices worldwide and part of AptarGroup, Inc. has...
Aptar PharmaCompany NewsAptar Pharma and RDD Online co-organize the second edition of RDD ASIA in Goa, IndiaAptar Pharma and RDD Online today announced the second Respiratory Drug Delivery (RDD®) Asia scienti...
Aptar PharmaCompany NewsAptar Pharma's Freepod nasal spray device with GlaxoSmithKline's Otrivin wins prestigious WPO WorldStar 2019 awardAptar Pharma, a leading provider of innovative drug delivery systems, has announced that its patente...
Aptar PharmaCompany NewsAptar Pharma's bidose nasal drug delivery device approved by US FDA for breakthrough treatment of depressionAptar Pharma, a leading drug delivery systems provider, has announced that its Bidose nasal spray de...
Aptar PharmaProduct InfoAptar Pharma's electronic lockout device approved by EMAAptar Pharma, a world leader in innovative drug delivery systems, is pleased to announce the approva...
Aptar PharmaProduct InfoAptar Pharma provides unit-dose nasal spray technology for treatment of opioid overdoseAptar Pharma has announced that it has provided the delivery system and regulatory support for Adap...
.jpg)
.jpg)
